Bristol-Myers Squibb Company
Market Cap
$121.31B
P/E Ratio
17.22
EPS
$3.46
Dividend Yield
4.14%
52-Week Range
$42.52 — $62.89
Volume
3.54M
Avg Volume
13.50M
Beta
0.27
P/E (TTM)
17.22
Forward P/E
9.65
PEG Ratio
1.05
P/S (TTM)
2.54
P/B (TTM)
6.64
P/FCF
15.34
EV/EBITDA
27.74x
EV/Sales
—
ROE (TTM)
0.39%
ROA (TTM)
0.08%
ROIC
0.05%
Gross Margin
0.68%
Operating Margin
0.26%
Net Margin
0.18%
Debt/Equity
2.55
Current Ratio
1.26
EPS Growth (YoY)
+0.81%
Revenue Growth (YoY)
+0.02%
EPS Growth (3Y)
-0.02%
EPS Growth (5Y)
+0.34%
Sales Growth (3Y)
+0.02%
Sales Growth (5Y)
+0.03%
EPS Est (This Year)
$6.17
EPS Est (Next Year)
$5.97
Dividend Yield
—
Annual Dividend
$0.63
Payout Ratio
0.57%
Frequency
—
Ex-Dividend Date
2026-01-02
Cash/Share
$5.23
Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $60.11(0.9% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
2.04B
Float
2.03B
Free Float %
99.84%
RSI (14)
76.95
SMA 20
$56.49
SMA 50
$54.48
SMA 200
$48.82
ATR (14)
1.43
Volatility (Week)
0.02%
Volatility (Month)
0.02%
Pattern
Doji
1 Day
+0.15%
1 Week
+8.70%
1 Month
+8.95%
3 Months
+30.35%
6 Months
+32.51%
1 Year
—
YTD
+13.84%
All-Time High
$63.33
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
US
Exchange
NYSE
IPO Date
1972-06-01
Employees
34100
CEO
Christopher S. Boerner
Index Membership
S&P 500
Website
https://www.bms.com
Bristol-Myers Squibb Company (BMY) is a healthcare company in the drug manufacturers - general industry listed on the NYSE. With a market capitalization of $121.31B, a P/E ratio of 17.22, and a dividend yield of 4.14%, BMY is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare BMY against other stocks using dozens of fundamental and technical filters.
Bristol-Myers Squibb Company (BMY) has a trailing twelve-month (TTM) P/E ratio of 17.22. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Bristol-Myers Squibb Company (BMY) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Bristol-Myers Squibb Company (BMY) has a market capitalization of $121.31 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on Bristol-Myers Squibb Company (BMY) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $60.11 implies 0.9% upside from the current price.
Bristol-Myers Squibb Company (BMY) has returned +13.84% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.